
| • |
Revenue of $827 million, an 18% increase compared to the prior year and a 5% decrease compared to the prior quarter
|
| • |
Income from operations of $12 million; net loss attributable to Tronox of $55 million; and adjusted net loss attributable to Tronox was $54 million (non-GAAP)
|
| • |
GAAP diluted loss per share was $0.34; Adjusted diluted loss per share was $0.34 (non-GAAP)
|
| • |
Adjusted EBITDA of $101 million; Adjusted EBITDA margin of 12.2% (non-GAAP)
|
| • |
Capital expenditures of $57 million
|
| • |
Generated free cash flow of $5 million (non-GAAP)
|
| • |
Expect Q4 2026 TiO2 volumes to decline sequentially in the high-single to low double-digit percentage range, primarily driven by seasonality
|
| • |
Expect Q4 2026 zircon volume levels to soften moderately sequentially, primarily due to inventory availability
|
| • |
Expect Q3 TiO2 pricing gains to be sustained in Q4 and zircon pricing to increase sequentially in the mid-single-digit percentage range
|
| • |
Q4 2026 Adjusted EBITDA expected to be $80-$90 million
|
| • |
Expect free cash flow to be a source of $20-$45 million for Q4 2026, resulting in a free cash flow use of $25-50 million for full year 2026, updated from previous expectations
primarily due to the unforeseen prolonged conflict in the Middle East, driving unanticipated raw material price headwinds and weaker sales volumes
|
|
($M unless otherwise noted)
|
Q3 2026
|
Q3 2025
|
Y-o-Y%∆
|
|
Q2 2026
|
Q-o-Q%∆
|
|
|||||||||||
|
Revenue
|
$
|
827 |
$
|
699 |
18
|
%
|
$
|
868
|
(5)
|
%
|
||||||||
|
TiO2
|
$
|
653
|
$
|
550
|
19
|
%
|
$
|
700 | (7) |
%
|
||||||||
|
Zircon
|
$
|
93
|
$
|
59 |
58
|
%
|
$
|
97
|
(4) |
%
|
||||||||
|
Other products
|
$
|
81
|
$
|
90 |
(10
|
)%
|
$
|
71
|
14 |
%
|
||||||||
|
Income (loss) from operations
|
$
|
12
|
|
$
|
(43
|
)
|
n/
|
m
|
$
|
(21
|
)
|
n/
|
m
|
|||||
|
Net (loss) attributable to Tronox
|
$
|
(55
|
)
|
$
|
(99
|
)
|
n/
|
m
|
$
|
(171
|
)
|
n/
|
m
|
|||||
|
GAAP diluted (loss) per share
|
$
|
(0.34
|
)
|
$
|
(0.63
|
)
|
n/
|
m
|
$
|
(1.07
|
)
|
n/
|
m
|
|||||
|
Adjusted diluted (loss) per share
|
$
|
(0.34
|
)
|
$
|
(0.46
|
)
|
n/
|
m
|
$
|
(0.51
|
)
|
n/
|
m
|
|||||
|
Adjusted EBITDA
|
$
|
101
|
$
|
74 |
36
|
%
|
$
|
73 |
38
|
%
|
||||||||
|
Adjusted EBITDA Margin %
|
12.2
|
%
|
10.6
|
%
|
160
|
bps |
8.4
|
%
|
380
|
bps | ||||||||
|
Free cash flow
|
$
|
5 |
$
|
(137
|
)
|
n/
|
m
|
$
|
60
|
|
n/
|
m
|
|
Y-o-Y % ∆
|
Q-o-Q % ∆
|
|||||
|
Volume
|
Price / Mix
|
FX
|
Volume
|
Price / Mix
|
FX
|
|
|
TiO2
|
10%
|
9%
|
0%
|
(11)%
|
4%
|
0%
|
|
Zircon
|
49%
|
9%
|
—
|
(13)%
|
9%
|
—
|
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||||||||||||
|
|
2026
|
2025
|
2026
|
2025
|
||||||||||||
|
Net sales
|
$
|
827
|
$
|
699
|
$
|
2,455
|
$
|
2,168
|
||||||||
|
Cost of goods sold
|
750
|
647
|
2,279
|
1,938
|
||||||||||||
|
Gross profit
|
77
|
52
|
176
|
230
|
||||||||||||
|
Restructuring and other charges
|
—
|
25
|
18
|
153
|
||||||||||||
|
Selling, general and administrative expenses
|
65
|
70
|
208
|
216
|
||||||||||||
|
Income (Loss) from operations
|
12
|
(43
|
)
|
(50
|
)
|
(139
|
)
|
|||||||||
|
Interest expense
|
(56
|
)
|
(48
|
)
|
(165
|
)
|
(135
|
)
|
||||||||
|
Interest income
|
1
|
1
|
3
|
4
|
||||||||||||
|
Other expense, net
|
(7
|
)
|
(2
|
)
|
(9
|
)
|
(9
|
)
|
||||||||
|
Loss before income taxes
|
(50
|
)
|
(92
|
)
|
(221
|
)
|
(279
|
)
|
||||||||
|
Income tax provision
|
(6
|
)
|
(8
|
)
|
(112
|
)
|
(17
|
)
|
||||||||
|
Net loss
|
(56
|
)
|
(100
|
)
|
(333
|
)
|
(296
|
)
|
||||||||
|
Net loss attributable to noncontrolling interest
|
(1
|
)
|
(1
|
)
|
(4
|
)
|
(2
|
)
|
||||||||
|
Net loss attributable to Tronox Holdings plc
|
$
|
(55
|
)
|
$
|
(99
|
)
|
$
|
(329
|
)
|
$
|
(294
|
)
|
||||
|
Loss per share:
|
||||||||||||||||
|
Basic
|
$
|
(0.34
|
)
|
$
|
(0.63
|
)
|
$
|
(2.06
|
)
|
$
|
(1.85
|
)
|
||||
|
Diluted
|
$
|
(0.34
|
)
|
$
|
(0.63
|
)
|
$
|
(2.06
|
)
|
$
|
(1.85
|
)
|
||||
|
Weighted average shares outstanding, basic (in thousands)
|
159,701
|
158,600
|
159,524
|
158,439
|
||||||||||||
|
Weighted average shares outstanding, diluted (in thousands)
|
159,701
|
158,600
|
159,524
|
158,439
|
||||||||||||
|
Other Operating Data:
|
||||||||||||||||
|
Capital expenditures
|
57
|
80
|
169
|
273
|
||||||||||||
|
Depreciation, depletion and amortization expense
|
76
|
75
|
227
|
220
|
||||||||||||
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||||||||||||
|
2026
|
2025
|
2026
|
2025
|
|||||||||||||
|
Net loss attributable to Tronox Holdings plc (U.S. GAAP)
|
$
|
(55
|
)
|
$
|
(99
|
)
|
$
|
(329
|
)
|
$
|
(294
|
)
|
||||
|
Gain on sale of Fuzhou (a)
|
—
|
—
|
(20
|
)
|
—
|
|||||||||||
|
Restructuring and other charges (b)
|
—
|
25
|
18
|
150
|
||||||||||||
|
Tax valuation allowance (c)
|
—
|
—
|
103
|
—
|
||||||||||||
|
Other (d)
|
1
|
2
|
4
|
3
|
||||||||||||
|
Adjusted net loss attributable to Tronox Holdings plc (non-U.S. GAAP)
|
$
|
(54
|
)
|
$
|
(72
|
)
|
$
|
(224
|
)
|
$
|
(141
|
)
|
||||
|
Diluted net loss per share (U.S. GAAP)
|
$
|
(0.34
|
)
|
$
|
(0.63
|
)
|
$
|
(2.06
|
)
|
$
|
(1.85
|
)
|
||||
|
Gain on sale of Fuzhou, per share
|
—
|
—
|
(0.13
|
)
|
—
|
|||||||||||
|
Restructuring and other charges, per share
|
—
|
0.16
|
0.12
|
0.94
|
||||||||||||
|
Tax valuation allowance, per share
|
—
|
—
|
0.65
|
—
|
||||||||||||
|
Other, per share
|
—
|
0.01
|
0.02
|
0.02
|
||||||||||||
|
Diluted adjusted net loss per share attributable to Tronox Holdings plc (non-U.S. GAAP) (1)
|
$
|
(0.34
|
)
|
$
|
(0.46
|
)
|
$
|
(1.40
|
)
|
$
|
(0.89
|
)
|
||||
|
Weighted average shares outstanding, diluted (in thousands)
|
159,701
|
158,600
|
159,524
|
158,439
|
||||||||||||
|
September 30, 2026
|
December 31, 2025
|
|||||||
|
ASSETS
|
||||||||
|
Current Assets
|
||||||||
|
Cash and cash equivalents
|
$
|
136
|
$
|
199
|
||||
|
Restricted cash
|
18
|
12
|
||||||
|
Accounts receivable (net of allowance for credit losses of $1 and $1 as of September 30, 2026 and December 31, 2025,
respectively)
|
348
|
289
|
||||||
|
Inventories, net
|
1,435
|
1,652
|
||||||
|
Prepaid and other assets
|
176
|
112
|
||||||
|
Income taxes receivable
|
2
|
1
|
||||||
|
Total current assets
|
2,115
|
2,265
|
||||||
|
Noncurrent Assets
|
||||||||
|
Property, plant and equipment, net
|
1,978
|
2,007
|
||||||
|
Mineral leaseholds, net
|
588
|
608
|
||||||
|
Intangible assets, net
|
197
|
214
|
||||||
|
Lease right of use assets, net
|
175
|
173
|
||||||
|
Deferred tax assets
|
723
|
833
|
||||||
|
Other long-term assets
|
115
|
117
|
||||||
|
Total assets
|
$
|
5,891
|
$
|
6,217
|
||||
|
LIABILITIES AND EQUITY
|
||||||||
|
Current Liabilities
|
||||||||
|
Accounts payable
|
$
|
437
|
$
|
481
|
||||
|
Accrued liabilities
|
239
|
274
|
||||||
|
Short-term lease liabilities
|
24
|
22
|
||||||
|
Obligations under inventory financing arrangement
|
49
|
50
|
||||||
|
Short-term debt
|
47
|
51
|
||||||
|
Long-term debt due within one year
|
39
|
39
|
||||||
|
Income taxes payable
|
3
|
2
|
||||||
|
Total current liabilities
|
838
|
919
|
||||||
|
Noncurrent Liabilities
|
||||||||
|
Long-term debt, net
|
3,116
|
3,132
|
||||||
|
Pension and postretirement healthcare benefits
|
79
|
81
|
||||||
|
Asset retirement obligations
|
213
|
198
|
||||||
|
Environmental liabilities
|
19
|
39
|
||||||
|
Long-term lease liabilities
|
152
|
148
|
||||||
|
Deferred tax liabilities
|
211
|
208
|
||||||
|
Other long-term liabilities
|
109
|
43
|
||||||
|
Total liabilities
|
4,737
|
4,768
|
||||||
|
Commitments and Contingencies
|
||||||||
|
Shareholders’ Equity
|
||||||||
|
Tronox Holdings plc ordinary shares, par value $0.01 — 159,704,662 shares issued and outstanding at September 30,
2026 and 158,557,858 shares issued and outstanding at December 31, 2025
|
2
|
2
|
||||||
|
Capital in excess of par value
|
2,095
|
2,103
|
||||||
|
(Accumulated deficit) retained earnings
|
(299
|
)
|
30
|
|||||
|
Accumulated other comprehensive loss
|
(673
|
)
|
(717
|
)
|
||||
|
Total Tronox Holdings plc shareholders’ equity
|
1,125
|
1,418
|
||||||
|
Noncontrolling interest
|
29
|
31
|
||||||
|
Total equity
|
1,154
|
1,449
|
||||||
|
Total liabilities and equity
|
$
|
5,891
|
$
|
6,217
|
||||
|
Nine Months Ended September 30,
|
||||||||
|
2026
|
2025
|
|||||||
|
Cash Flows from Operating Activities:
|
||||||||
|
Net loss
|
$
|
(333
|
)
|
$
|
(296
|
)
|
||
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
||||||||
|
Depreciation, depletion and amortization
|
227
|
220
|
||||||
|
Deferred income taxes
|
109
|
14
|
||||||
|
Share-based compensation expense
|
17
|
14
|
||||||
|
Amortization of deferred debt issuance costs and discount on debt
|
9
|
7
|
||||||
|
Restructuring and other charges
|
18
|
153
|
||||||
|
Other non-cash items affecting net loss
|
23
|
43
|
||||||
|
Changes in assets and liabilities:
|
||||||||
|
Increase in accounts receivable, net of allowance for credit losses
|
(59
|
)
|
(24
|
)
|
||||
|
Decrease (increase) in inventories, net
|
214
|
(73
|
)
|
|||||
|
Decrease in prepaid and other assets
|
-
|
39
|
||||||
|
Restructuring payments
|
(35
|
)
|
(57
|
)
|
||||
|
Decrease in accounts payable and accrued liabilities
|
(73
|
)
|
(70
|
)
|
||||
|
Net changes in income tax payables and receivables
|
1
|
(2
|
)
|
|||||
|
Changes in other non-current assets and liabilities
|
(19
|
)
|
(29
|
)
|
||||
|
Cash provided by (used in) operating activities
|
99
|
(61
|
)
|
|||||
|
Cash Flows from Investing Activities:
|
||||||||
|
Capital expenditures
|
(169
|
)
|
(273
|
)
|
||||
|
Loans
|
-
|
15
|
||||||
|
Proceeds from dispositions and asset sales
|
15
|
3
|
||||||
|
Cash used in investing activities
|
(154
|
)
|
(255
|
)
|
||||
|
Cash Flows from Financing Activities:
|
||||||||
|
Repayments of short-term debt
|
(102
|
)
|
(136
|
)
|
||||
|
Repayments of long-term debt
|
(23
|
)
|
(21
|
)
|
||||
|
Repayments of sale and leaseback transactions
|
(2
|
)
|
-
|
|||||
|
Repayments of inventory financing arrangement
|
(100
|
)
|
-
|
|||||
|
Proceeds from inventory financing arrangement
|
99
|
50
|
||||||
|
Proceeds from sale and leaseback transaction
|
75
|
-
|
||||||
|
Proceeds from short-term debt
|
80
|
100
|
||||||
|
Proceeds from long-term debt
|
-
|
400
|
||||||
|
Debt issuance costs
|
(2
|
)
|
(7
|
)
|
||||
|
Sale and leaseback transaction costs
|
(1
|
)
|
-
|
|||||
|
Dividends paid
|
(24
|
)
|
(40
|
)
|
||||
|
Restricted stock and performance-based shares settled in cash for withholding taxes
|
-
|
(1
|
)
|
|||||
|
Cash provided by financing activities
|
-
|
345
|
||||||
|
Effects of exchange rate changes on cash and cash equivalents and restricted cash
|
(2
|
)
|
5
|
|||||
|
Net (decrease) increase in cash and cash equivalents and restricted cash
|
(57
|
)
|
34
|
|||||
|
Cash and cash equivalents and restricted cash at beginning of period
|
211
|
152
|
||||||
|
Cash and cash equivalents and restricted cash at end of period
|
$
|
154
|
$
|
186
|
||||
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||||||||||||
|
2026
|
2025
|
2026
|
2025
|
|||||||||||||
|
Net loss (U.S. GAAP)
|
$
|
(56
|
)
|
$
|
(100
|
)
|
$
|
(333
|
)
|
$
|
(296
|
)
|
||||
|
Interest expense
|
56
|
48
|
165
|
135
|
||||||||||||
|
Interest income
|
(1
|
)
|
(1
|
)
|
(3
|
)
|
(4
|
)
|
||||||||
|
Income tax provision
|
6
|
8
|
112
|
17
|
||||||||||||
|
Depreciation, depletion and amortization expense
|
76
|
75
|
227
|
220
|
||||||||||||
|
EBITDA (non-U.S. GAAP)
|
81
|
30
|
168
|
72
|
||||||||||||
|
Gain on sale of Fuzhou (a)
|
—
|
—
|
(20
|
)
|
—
|
|||||||||||
|
Share-based compensation (b)
|
6
|
5
|
17
|
14
|
||||||||||||
|
Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (c)
|
5
|
6
|
15
|
20
|
||||||||||||
|
Accounts receivable securitization program (d)
|
3
|
3
|
10
|
10
|
||||||||||||
|
Foreign currency remeasurement (e)
|
2
|
—
|
16
|
(1
|
)
|
|||||||||||
|
Restructuring and other charges (f)
|
—
|
25
|
18
|
153
|
||||||||||||
|
Other items (g)
|
4
|
5
|
12
|
11
|
||||||||||||
|
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
101
|
$
|
74
|
$
|
236
|
$
|
279
|
||||||||
|
Three Months Ended September 30,
|
||||||||
|
2026
|
2025
|
|||||||
|
Net sales
|
$
|
827
|
$
|
699
|
||||
|
Net loss (U.S. GAAP)
|
$
|
(56
|
)
|
$
|
(100
|
)
|
||
|
Net loss (U.S. GAAP) as a % of Net sales
|
(6.8
|
)%
|
(14.3
|
)%
|
||||
|
Adjusted EBITDA (non-U.S. GAAP) (see above) as a % of Net sales
|
12.2
|
%
|
10.6
|
%
|
||||
|
September 30, 2026
|
December 31, 2025
|
|||||||
|
Long-term debt, net
|
$
|
3,116
|
$
|
3,132
|
||||
|
Short-term debt
|
47
|
51
|
||||||
|
Long-term debt due within one year
|
39
|
39
|
||||||
|
(Less) Cash and cash equivalents
|
(136
|
)
|
(199
|
)
|
||||
|
Net debt (1)
|
$
|
3,066
|
$
|
3,023
|
||||
|
Trailing-twelve month Adjusted EBITDA (non-U.S. GAAP)
|
$
|
293
|
$
|
336
|
||||
|
Net debt to trailing-twelve month Adjusted EBITDA (non-U.S. GAAP) (see above)
|
10.5
|
x
|
9.0
|
x
|
||||
|
Nine Months Ended
September 30, 2026
|
Six Months Ended
June 30, 2026
|
Three Months Ended
September 30, 2026
|
||||||||||
|
Cash provided by operating activities
|
$
|
99
|
$
|
37
|
$
|
62
|
||||||
|
Capital expenditures
|
(169
|
)
|
(112
|
)
|
(57
|
)
|
||||||
|
Free cash flow (non-U.S. GAAP)
|
$
|
(70
|
)
|
$
|
(75
|
)
|
$
|
5
|
||||
|
Three Months Ended
|
Trailing Twelve Month
Adjusted EBITDA
|
|||||||||||||||||||
|
December 31, 2025
|
March 31, 2026
|
June 30, 2026
|
September 30, 2026
|
|||||||||||||||||
|
Net loss (U.S. GAAP)
|
$
|
(177
|
)
|
$
|
(104
|
)
|
$
|
(173
|
)
|
$
|
(56
|
)
|
$
|
(510
|
)
|
|||||
|
Interest expense
|
54
|
53
|
56
|
56
|
219
|
|||||||||||||||
|
Interest income
|
(2
|
)
|
(2
|
)
|
—
|
(1
|
)
|
(5
|
)
|
|||||||||||
|
Income tax provision (benefit)
|
(2
|
)
|
—
|
106
|
6
|
110
|
||||||||||||||
|
Depreciation, depletion and amortization expense
|
82
|
75
|
76
|
76
|
309
|
|||||||||||||||
|
EBITDA (non-U.S. GAAP)
|
(45
|
)
|
22
|
65
|
81
|
123
|
||||||||||||||
|
Gain on sale of Fuzhou (a)
|
—
|
—
|
(20
|
)
|
—
|
(20
|
)
|
|||||||||||||
|
Share-based compensation (b)
|
6
|
6
|
5
|
6
|
23
|
|||||||||||||||
|
Foreign currency remeasurement (c)
|
7
|
7
|
7
|
2
|
23
|
|||||||||||||||
|
Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (d)
|
(11
|
)
|
4
|
6
|
5
|
4
|
||||||||||||||
|
Accounts receivable securitization program (e)
|
3
|
3
|
4
|
3
|
13
|
|||||||||||||||
|
Restructuring and other charges (f)
|
79
|
14
|
4
|
—
|
97
|
|||||||||||||||
|
Other items (g)
|
18
|
6
|
2
|
4
|
30
|
|||||||||||||||
|
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
57
|
$
|
62
|
$
|
73
|
$
|
101
|
$
|
293
|
||||||||||